• Exchange: Frankfurt
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

V16:GR

176.640 EUR 2.144 1.20%

As of 09:57:00 ET on 11/21/2014.

Snapshot for Virbac SA (V16)

Open: 180.017 Day's Range: 176.640 - 180.570 Volume: 0
Previous Close: 178.784 52wk Range: 138.715 - 183.450 1-Yr Rtn: +20.40%

Stock Chart for V16

No chart data available.
  • V16:GR 179.351
  • 1D
  • 1M
  • 1Y
178.784
Interactive V16 Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for V16

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) 24.0131
Relative P/E vs. DAX -
Earnings Per Share (EUR) (ttm) -
Est. EPS (EUR) (12/2014) 7.3560
Est. PEG Ratio -
Market Cap (M EUR) 1,494.02
Shares Outstanding (M) 8.46
30 Day Average Volume 0
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield 1.08%
Cash Dividend (EUR) 1.9000
Dividend Ex-Date 06/20/2014
5 Year Dividend Growth -
Next Earnings Announcement 03/09/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for V16

  • Revenue
  • Net Income (M/EUR)
  • Profit Margin (%)

Company Profile & Key Executives for V16

Virbac SA manufactures antibiotics, worm medicines, and vaccines for veterinary use. The Company's products are distributed in the United States, Europe, Asia and South America.

Eric MareeChairman-Mgmt BoardMichel GaraudetChief Financial Officer
Christian KarstExec VP:Corporate DevSebastien HuronDir:Commercial Ops
More Company Profile & Key Executives for V16

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
  • V16 News

  • Industry News

Advertisement
Sponsored Links
Advertisements
sec ||= nil